$CGIX Recent News IPO scorecard: Rocket Fuel, Fi
Post# of 44803
![Avatar](/images/ProfileImages/410421673_9050_Stock_Tracker.jpg)
IPO scorecard: Rocket Fuel, FireEye, Benefitfocus 3:05 p.m. Sept. 24, 2013 - MarketWatch.com
Cancer Genetics Names John Pappajohn Chairman of the Board of Directors 6:01 a.m. Jan. 6, 2014 - benzinga.com
What Mark Cuban And George Soros Have In Common 10:34 a.m. Dec. 12, 2013 - Seeking Alpha
Not Your Father's Diagnostics: Ram Selvaraju On How Molecular Genomics Invigorate The Sector 4:27 p.m. Dec. 6, 2013 - Seeking Alpha
Rexahn's Akt-1 Inhibitor To Begin Phase II Trials For Kidney Treatment 1:47 p.m. Nov. 25, 2013 - Seeking Alpha
Cancer Genetics Launches Proprietary DNA-Based Cervical Cancer Diagnostic Test in US 7:17 a.m. Nov. 18, 2013 - benzinga.com
2 Attractive But Very Speculative Biotech Plays 9:55 a.m. Nov. 15, 2013 - Seeking Alpha
UPDATE: Aegis Capital Reiterates on Cancer Genetics Following Better-Than-Expected 3Q 2013 Financial Results 10:36 a.m. Nov. 14, 2013 - benzinga.com
Cancer Genetics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 2:26 a.m. Nov. 14, 2013 - Seeking Alpha
10-Q: CANCER GENETICS, INC 4:28 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Senesco Technologies: A Potential $26 Stock Trading At $5 11:09 a.m. Nov. 4, 2013 - Seeking Alpha
Cancer Genetics Shares Rally As Feltl Analyst Getting More Bullish 9:02 a.m. Oct. 2, 2013 - benzinga.com
NextGxDx and athenahealth Join Forces - Analyst Blog 5:10 p.m. Oct. 1, 2013 - Zacks.com
Billions To Be Made In Diagnostics 1:38 p.m. Sept. 11, 2013 - Seeking Alpha
Cancer Genetics: High-End Diagnostics For Personal Cancer Treatment 3:29 p.m. Sept. 5, 2013 - Seeking Alpha
Cancer Genetics Prices 1.5M Share Offering at $10.00/Share 6:10 p.m. Aug. 13, 2013 - benzinga.com
10-Q: CANCER GENETICS, INC 7:18 a.m. Aug. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
Expect a Bustling Week for IPOs 8:03 a.m. March 18, 2013 - InvestorPlace.com
IPO Preview: Cancer Genetics 5:44 p.m. Feb. 12, 2013 - Seeking Alpha
Cancer Genetics, Inc. to Present at Two Investor Conferences in January 7:00 a.m. Jan. 8, 2014 - GlobeNewswire
Cancer Genetics Appoints John Pappajohn Chairman of the Board of Directors 7:00 a.m. Jan. 6, 2014 - GlobeNewswire
RedChip Issues Research Update on Cancer Genetics 9:02 a.m. Dec. 19, 2013 - GlobeNewswire
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader 7:55 a.m. Dec. 19, 2013 - GlobeNewswire
RedChip TV Features CGIX, SPEX, and ICLD on This Week's Show on Fox Business and Bloomberg 12:25 p.m. Nov. 29, 2013 - GlobeNewswire
Cancer Genetics, Inc. Will Showcase a Novel Diagnostic and Prognostic Test for Diffuse, Large B-Cell Lymphoma (DLBCL) at the American Society of Hematology Annual Meeting in New Orleans 8:01 a.m. Nov. 25, 2013 - GlobeNewswire
Cancer Genetics, Inc. and Mayo Clinic Provide Update on Their Joint Venture to Develop Next Generation Sequencing Company Focused on Areas of Critical Need in Oncology 8:30 a.m. Nov. 22, 2013 - GlobeNewswire
Cancer Genetics, Inc. Featured in Two Key Latin American Genetics Conferences 8:00 a.m. Nov. 21, 2013 - GlobeNewswire
Cancer Genetics, Inc. Announces U.S. Launch of Its Proprietary DNA-Based Cervical Cancer Diagnostic Test, FHACT(TM) 8:15 a.m. Nov. 18, 2013 - GlobeNewswire
Cancer Genetics, Inc. Announces Third Quarter Financial Results 4:01 p.m. Nov. 13, 2013 - GlobeNewswire
Cancer Genetics, Inc. Announces Conference Call to Discuss Third Quarter Results 7:59 a.m. Nov. 11, 2013 - GlobeNewswire
Cancer Genetics to Showcase Research on Its Novel, Patent-Protected, Kidney Cancer Diagnostic Array at the Association for Molecular Pathology 2013 Annual Conference 7:59 a.m. Nov. 7, 2013 - GlobeNewswire
Cancer Genetics, Inc. Granted Patent for Kidney Cancer Diagnosis & Typing Using a Proprietary Genomic Method 7:59 a.m. Nov. 6, 2013 - GlobeNewswire
Cancer Genetics Announces Closing of Public Offering of $46 Million of Shares of Common Stock 3:10 p.m. Oct. 28, 2013 - GlobeNewswire
Cancer Genetics Announces Exercise of Underwriters' Over-Allotment Option 5:21 p.m. Oct. 24, 2013 - GlobeNewswire
Cancer Genetics Announces Pricing of Public Offering of 2,858,000 Shares of Common Stock 5:11 p.m. Oct. 22, 2013 - GlobeNewswire
RedChip Announces Presentation Schedule for Oct. 23-24 Emerging Growth Showcase 11:53 a.m. Oct. 18, 2013 - GlobeNewswire
RedChip Issues Research Profile on Cancer Genetics 7:15 a.m. Oct. 11, 2013 - GlobeNewswire
Exclusive Video Interviews With CEOs Now on Equities.com: CGIX, CYTR, GWPH, HTBX, OPXA 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
Cancer Genetics, Inc. Will Open Precision Medicine Conference With Keynote Presentation 9:15 a.m. Oct. 8, 2013 - GlobeNewswire
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)